How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
47
CVS Quote, Financials, Valuation and Earnings
Last price:
$65.42
Seasonality move
:
2.65%
Day range:
$64.30 - $65.75
52-week range:
$43.56 - $71.45
Dividend yield:
4.06%
P/E ratio:
17.88x
P/S ratio:
0.22x
P/B ratio:
1.09x
Volume:
8.2M
Avg. volume:
10.6M
1-year change:
-6%
Market cap:
$82.5B
Revenue:
$372.8B
EPS (TTM):
$3.66
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | |
| Revenue Growth (YoY) | 4.65% | 8.71% | 10.39% | 10.95% | 4.2% | |
| Cost of Revenues | $219.7B | $240B | $268B | $303.3B | $321.4B | |
| Gross Profit | $49B | $52.1B | $54.5B | $54.4B | $51.4B | |
| Gross Profit Margin | 18.25% | 17.84% | 16.9% | 15.21% | 13.79% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.2B | -$2.1B | -$8.2B | -$768M | -$689M | |
| Operating Expenses | $35.1B | $37B | $38.2B | $39.8B | $41.6B | |
| Operating Income | $13.9B | $15.1B | $16.3B | $14.6B | $9.8B | |
| Net Interest Expenses | $2.9B | $2.5B | $2.3B | $2.7B | $3B | |
| EBT. Incl. Unusual Items | $9.8B | $10.5B | $5.8B | $11.2B | $6.1B | |
| Earnings of Discontinued Ops. | -$9M | -- | -- | -- | -- | |
| Income Tax Expense | $2.6B | $2.5B | $1.5B | $2.8B | $1.6B | |
| Net Income to Company | $7.2B | $8B | $4.3B | $8.4B | $4.6B | |
| Minority Interest in Earnings | -$13M | $12M | -$16M | -$24M | $28M | |
| Net Income to Common Excl Extra Items | $7.2B | $8B | $4.3B | $8.3B | $4.6B | |
| Basic EPS (Cont. Ops) | $5.48 | $6.07 | $3.29 | $6.49 | $3.67 | |
| Diluted EPS (Cont. Ops) | $5.46 | $6.02 | $3.26 | $6.47 | $3.66 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $17.1B | $17.5B | $12.3B | $18.2B | $13.7B | |
| EBIT | $12.7B | $13B | $8.1B | $13.8B | $9.1B | |
| Revenue (Reported) | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | |
| Operating Income (Reported) | $13.9B | $15.1B | $16.3B | $14.6B | $9.8B | |
| Operating Income (Adjusted) | $12.7B | $13B | $8.1B | $13.8B | $9.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $69.6B | $76.6B | $83.8B | $93.8B | $97.7B | |
| Revenue Growth (YoY) | 3.98% | 10.14% | 9.45% | 11.89% | 4.15% | |
| Cost of Revenues | $57.6B | $62.9B | $70B | $79.9B | $84.8B | |
| Gross Profit | $12B | $13.7B | $13.9B | $13.9B | $12.9B | |
| Gross Profit Margin | 17.19% | 17.92% | 16.53% | 14.79% | 13.2% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$621M | -$1.4B | -$68M | $22M | $406M | |
| Operating Expenses | $9.4B | $10B | $10.1B | $10.5B | $10.4B | |
| Operating Income | $2.5B | $3.7B | $3.8B | $3.4B | $2.5B | |
| Net Interest Expenses | $678M | $608M | $552M | $690M | $758M | |
| EBT. Incl. Unusual Items | $1.2B | $1.7B | $3.2B | $2.7B | $2.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $241M | $300M | $818M | $658M | $503M | |
| Net Income to Company | $975M | $1.4B | $2.3B | $2B | $1.6B | |
| Minority Interest in Earnings | -$2M | $10M | $2M | -$1M | $21M | |
| Net Income to Common Excl Extra Items | $973M | $1.4B | $2.3B | $2B | $1.6B | |
| Basic EPS (Cont. Ops) | $0.74 | $0.99 | $1.76 | $1.59 | $1.31 | |
| Diluted EPS (Cont. Ops) | $0.74 | $0.98 | $1.75 | $1.58 | $1.30 | |
| Weighted Average Basic Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | |
| EBITDA | $3B | $3.4B | $4.7B | $4.5B | $4B | |
| EBIT | $1.9B | $2.3B | $3.7B | $3.4B | $2.9B | |
| Revenue (Reported) | $69.6B | $76.6B | $83.8B | $93.8B | $97.7B | |
| Operating Income (Reported) | $2.5B | $3.7B | $3.8B | $3.4B | $2.5B | |
| Operating Income (Adjusted) | $1.9B | $2.3B | $3.7B | $3.4B | $2.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $219.7B | $240B | $268B | $303.3B | $321.4B | |
| Gross Profit | $49B | $52.1B | $54.5B | $54.4B | $51.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$1.2B | -$2.1B | -$8.2B | -$768M | -$689M | |
| Operating Expenses | $35.1B | $37B | $38.2B | $39.8B | $41.6B | |
| Operating Income | $13.9B | $15.1B | $16.3B | $14.6B | $9.8B | |
| Net Interest Expenses | $2.9B | $2.5B | $2.3B | $2.7B | $3B | |
| EBT. Incl. Unusual Items | $9.8B | $10.5B | $5.8B | $11.2B | $6.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.6B | $2.5B | $1.5B | $2.8B | $1.6B | |
| Net Income to Company | $7.2B | $8B | $4.3B | $8.4B | $4.6B | |
| Minority Interest in Earnings | -$13M | $12M | -$16M | -$24M | $28M | |
| Net Income to Common Excl Extra Items | $7.2B | $8B | $4.3B | $8.3B | $4.6B | |
| Basic EPS (Cont. Ops) | $5.48 | $6.00 | $3.27 | $6.49 | $3.67 | |
| Diluted EPS (Cont. Ops) | $5.46 | $5.96 | $3.22 | $6.46 | $3.66 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $17.1B | $17.5B | $12.3B | $18.2B | $13.7B | |
| EBIT | $12.7B | $13B | $8.1B | $13.8B | $9.1B | |
| Revenue (Reported) | $268.7B | $292.1B | $322.5B | $357.8B | $372.8B | |
| Operating Income (Reported) | $13.9B | $15.1B | $16.3B | $14.6B | $9.8B | |
| Operating Income (Adjusted) | $12.7B | $13B | $8.1B | $13.8B | $9.1B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $292.1B | $322.5B | $357.8B | $372.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $240B | $268B | $303.3B | $321.4B | -- | |
| Gross Profit | $52.1B | $54.5B | $54.4B | $51.4B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$2.1B | -$8.2B | -$768M | -$689M | -- | |
| Operating Expenses | $37B | $38.2B | $39.8B | $41.6B | -- | |
| Operating Income | $15.1B | $16.3B | $14.6B | $9.8B | -- | |
| Net Interest Expenses | $2.5B | $2.3B | $2.7B | $3B | -- | |
| EBT. Incl. Unusual Items | $10.5B | $5.8B | $11.2B | $6.1B | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.5B | $1.5B | $2.8B | $1.6B | -- | |
| Net Income to Company | $8B | $4.3B | $8.4B | $4.6B | -- | |
| Minority Interest in Earnings | $12M | -$16M | -$24M | $28M | -- | |
| Net Income to Common Excl Extra Items | $8B | $4.3B | $8.3B | $4.6B | -- | |
| Basic EPS (Cont. Ops) | $6.00 | $3.27 | $6.49 | $3.67 | -- | |
| Diluted EPS (Cont. Ops) | $5.96 | $3.22 | $6.46 | $3.66 | -- | |
| Weighted Average Basic Share | $5.3B | $5.2B | $5.1B | $5B | -- | |
| Weighted Average Diluted Share | $5.3B | $5.3B | $5.2B | $5B | -- | |
| EBITDA | $17.5B | $12.3B | $18.2B | $13.7B | -- | |
| EBIT | $13B | $8.1B | $13.8B | $9.1B | -- | |
| Revenue (Reported) | $292.1B | $322.5B | $357.8B | $372.8B | -- | |
| Operating Income (Reported) | $15.1B | $16.3B | $14.6B | $9.8B | -- | |
| Operating Income (Adjusted) | $13B | $8.1B | $13.8B | $9.1B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.9B | $9.4B | $12.9B | $8.2B | $8.6B | |
| Short Term Investments | $3B | $3.1B | $2.8B | $3.3B | $2.4B | |
| Accounts Receivable, Net | $9.7B | $10.5B | $11.7B | $15.6B | $14.6B | |
| Inventory | $18.5B | $17.8B | $19.1B | $18B | $18.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.3B | $5.3B | $2.6B | $3.2B | $3.1B | |
| Total Current Assets | $56.4B | $60B | $65.6B | $67.9B | $68.6B | |
| Property Plant And Equipment | $33.3B | $32B | $30.7B | $30.4B | $28.9B | |
| Long-Term Investments | $20.8B | $23B | $21.1B | $23B | $28.9B | |
| Goodwill | $79.6B | $79.1B | $78.2B | $91.3B | $91.3B | |
| Other Intangibles | $31.1B | $29B | $24.8B | $29.2B | $27.3B | |
| Other Long-Term Assets | $4.6B | $4.7B | $4.6B | $4.7B | $4.8B | |
| Total Assets | $230.7B | $233B | $228.3B | $249.7B | $253.2B | |
| Accounts Payable | $11.1B | $12.5B | $14.8B | $14.9B | $15.9B | |
| Accrued Expenses | $14.2B | $17.7B | $18.7B | $23.5B | $20.8B | |
| Current Portion Of Long-Term Debt | $5.4B | $4.2B | $1.8B | $2.8B | $3.6B | |
| Current Portion Of Capital Lease Obligations | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Other Current Liabilities | $5.8B | $5.6B | $2.8B | $1.1B | $1.2B | |
| Total Current Liabilities | $62B | $67.8B | $69.4B | $79.2B | $84.6B | |
| Long-Term Debt | $59.2B | $52B | $50.5B | $58.6B | $60.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $161B | $157.6B | $156.5B | $173.1B | $177.5B | |
| Common Stock | $46.5B | $47.4B | $48.2B | $49B | $49.7B | |
| Other Common Equity Adj | $1.4B | $965M | -$1.3B | -$297M | -$120M | |
| Common Equity | $69.4B | $75.1B | $71.5B | $76.5B | $75.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $312M | $306M | $300M | $175M | $170M | |
| Total Equity | $69.7B | $75.4B | $71.8B | $76.6B | $75.7B | |
| Total Liabilities and Equity | $230.7B | $233B | $228.3B | $249.7B | $253.2B | |
| Cash and Short Terms | $10.9B | $12.5B | $15.7B | $11.5B | $11B | |
| Total Debt | $64.6B | $56.2B | $52.3B | $61.6B | $66.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $7.9B | $9.4B | $12.9B | $8.2B | $8.6B | |
| Short Term Investments | $3B | $3.1B | $2.8B | $3.3B | $2.4B | |
| Accounts Receivable, Net | $9.7B | $10.5B | $11.7B | $15.6B | $14.6B | |
| Inventory | $18.5B | $17.8B | $19.1B | $18B | $18.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.3B | $5.3B | $2.6B | $3.2B | $3.1B | |
| Total Current Assets | $56.4B | $60B | $65.6B | $67.9B | $68.6B | |
| Property Plant And Equipment | $33.3B | $32B | $30.7B | $30.4B | $28.9B | |
| Long-Term Investments | $20.8B | $23B | $21.1B | $23B | $28.9B | |
| Goodwill | $79.6B | $79.1B | $78.2B | $91.3B | $91.3B | |
| Other Intangibles | $31.1B | $29B | $24.8B | $29.2B | $27.3B | |
| Other Long-Term Assets | $4.6B | $4.7B | $4.6B | $4.7B | $4.8B | |
| Total Assets | $230.7B | $233B | $228.3B | $249.7B | $253.2B | |
| Accounts Payable | $11.1B | $12.5B | $14.8B | $14.9B | $15.9B | |
| Accrued Expenses | $14.2B | $17.7B | $18.7B | $23.5B | $20.8B | |
| Current Portion Of Long-Term Debt | $5.4B | $4.2B | $1.8B | $2.8B | $3.6B | |
| Current Portion Of Capital Lease Obligations | $1.6B | $1.6B | $1.7B | $1.7B | $1.8B | |
| Other Current Liabilities | $5.8B | $5.6B | $2.8B | $1.1B | $1.2B | |
| Total Current Liabilities | $62B | $67.8B | $69.4B | $79.2B | $84.6B | |
| Long-Term Debt | $59.2B | $52B | $50.5B | $58.6B | $60.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $161B | $157.6B | $156.5B | $173.1B | $177.5B | |
| Common Stock | $46.5B | $47.4B | $48.2B | $49B | $49.7B | |
| Other Common Equity Adj | $1.4B | $965M | -$1.3B | -$297M | -$120M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $312M | $306M | $300M | $175M | $170M | |
| Total Equity | $69.7B | $75.4B | $71.8B | $76.6B | $75.7B | |
| Total Liabilities and Equity | $230.7B | $233B | $228.3B | $249.7B | $253.2B | |
| Cash and Short Terms | $10.9B | $12.5B | $15.7B | $11.5B | $11B | |
| Total Debt | $64.6B | $56.2B | $52.3B | $61.6B | $66.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $8B | $4.3B | $8.4B | $4.6B | |
| Depreciation & Amoritzation | $4.4B | $4.5B | $4.2B | $4.4B | $4.6B | |
| Stock-Based Compensation | $400M | $484M | $447M | $588M | $540M | |
| Change in Accounts Receivable | -$1.5B | -$2.7B | -$3B | -$6.3B | -$1.3B | |
| Change in Inventories | -$973M | $735M | -$1.4B | $1.2B | -$102M | |
| Cash From Operations | $15.9B | $18.3B | $16.2B | $13.4B | $9.1B | |
| Capital Expenditures | $2.4B | $2.5B | $2.7B | $3B | $2.8B | |
| Cash Acquisitions | -$26M | -$146M | -$1.4B | -$16.6B | -$95M | |
| Cash From Investing | -$5.5B | -$5.3B | -$5B | -$20.9B | -$7.6B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.6B | -$2.9B | -$3.1B | -$3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10B | $987M | -- | $16.1B | $9.8B | |
| Long-Term Debt Repaid | -$15.6B | -$10.3B | -$4.2B | -$8.2B | -$4.8B | |
| Repurchase of Common Stock | -- | -- | -$3.5B | -$2B | -$3B | |
| Other Financing Activities | $337M | -$13M | -$449M | -$382M | -$159M | |
| Cash From Financing | -$7.7B | -$11.4B | -$10.5B | $2.7B | -$1.1B | |
| Beginning Cash (CF) | $8.4B | $11B | $12.7B | $13.3B | $8.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6B | $1.6B | $614M | -$4.8B | $359M | |
| Ending Cash (CF) | $11B | $12.7B | $13.3B | $8.5B | $8.9B | |
| Levered Free Cash Flow | $13.4B | $15.7B | $13.5B | $10.4B | $6.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $975M | $1.4B | $2.3B | $2B | $1.6B | |
| Depreciation & Amoritzation | $1.1B | $1.1B | $1B | $1.1B | $1.1B | |
| Stock-Based Compensation | $112M | $138M | $106M | $127M | $137M | |
| Change in Accounts Receivable | $2.1B | $801M | -$962M | -$2.3B | -$315M | |
| Change in Inventories | -$1B | -$362M | -$1B | -$72M | -$457M | |
| Cash From Operations | $3.6B | $4B | -$2B | -$2.6B | $1.9B | |
| Capital Expenditures | $713M | $597M | $688M | $911M | $768M | |
| Cash Acquisitions | -$32M | -$11M | $671M | -$120M | -$10M | |
| Cash From Investing | -$1.2B | -$1.4B | -$119M | -$1.2B | -$547M | |
| Dividends Paid (Ex Special Dividend) | -$644M | -$660M | -$719M | -$779M | -$838M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2B | -- | -- | $200M | $4.3B | |
| Long-Term Debt Repaid | -$5.1B | -$2.4B | -$16M | -$432M | -$3.1B | |
| Repurchase of Common Stock | -- | -- | -$1.5B | $1M | -- | |
| Other Financing Activities | $452M | $68M | $7M | $3M | $44M | |
| Cash From Financing | -$3.3B | -$2.9B | -$2.2B | -$972M | $431M | |
| Beginning Cash (CF) | $9.5B | $13B | $17.6B | $13.4B | $7.1B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$943M | -$349M | -$4.3B | -$4.9B | $1.7B | |
| Ending Cash (CF) | $11B | $12.7B | $13.3B | $8.5B | $8.9B | |
| Levered Free Cash Flow | $2.9B | $3.4B | -$2.6B | -$3.5B | $1.1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $7.2B | $8B | $4.3B | $8.4B | $4.6B | |
| Depreciation & Amoritzation | $4.4B | $4.5B | $4.2B | $4.4B | $4.6B | |
| Stock-Based Compensation | $400M | $484M | $447M | $588M | $540M | |
| Change in Accounts Receivable | -$1.5B | -$2.7B | -$3B | -$6.3B | -$1.3B | |
| Change in Inventories | -$973M | $735M | -$1.4B | $1.2B | -$102M | |
| Cash From Operations | $15.9B | $18.3B | $16.2B | $13.4B | $9.1B | |
| Capital Expenditures | $2.4B | $2.5B | $2.7B | $3B | $2.8B | |
| Cash Acquisitions | -$26M | -$146M | -$1.4B | -$16.6B | -$95M | |
| Cash From Investing | -$5.5B | -$5.3B | -$5B | -$20.9B | -$7.6B | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.6B | -$2.9B | -$3.1B | -$3.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $10B | $987M | -- | $16.1B | $9.8B | |
| Long-Term Debt Repaid | -$15.6B | -$10.3B | -$4.2B | -$8.2B | -$4.8B | |
| Repurchase of Common Stock | -- | -- | -$3.5B | -$2B | -$3B | |
| Other Financing Activities | $337M | -$13M | -$449M | -$382M | -$159M | |
| Cash From Financing | -$7.7B | -$11.4B | -$10.5B | $2.7B | -$1.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.6B | $1.6B | $614M | -$4.8B | $359M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $13.4B | $15.7B | $13.5B | $10.4B | $6.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $8B | $4.3B | $8.4B | $4.6B | -- | |
| Depreciation & Amoritzation | $4.5B | $4.2B | $4.4B | $4.6B | -- | |
| Stock-Based Compensation | $484M | $447M | $588M | $540M | -- | |
| Change in Accounts Receivable | -$2.7B | -$3B | -$6.3B | -$1.3B | -- | |
| Change in Inventories | $735M | -$1.4B | $1.2B | -$102M | -- | |
| Cash From Operations | $18.3B | $16.2B | $13.4B | $9.1B | -- | |
| Capital Expenditures | $2.5B | $2.7B | $3B | $2.8B | -- | |
| Cash Acquisitions | -$146M | -$1.4B | -$16.6B | -$95M | -- | |
| Cash From Investing | -$5.3B | -$5B | -$20.9B | -$7.6B | -- | |
| Dividends Paid (Ex Special Dividend) | -$2.6B | -$2.9B | -$3.1B | -$3.4B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $987M | -- | $16.1B | $9.8B | -- | |
| Long-Term Debt Repaid | -$10.3B | -$4.2B | -$8.2B | -$4.8B | -- | |
| Repurchase of Common Stock | -- | -$3.5B | -$2B | -$3B | -- | |
| Other Financing Activities | -$13M | -$449M | -$382M | -$159M | -- | |
| Cash From Financing | -$11.4B | -$10.5B | $2.7B | -$1.1B | -- | |
| Beginning Cash (CF) | $43.3B | $54.3B | $55.8B | $38.6B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.6B | $614M | -$4.8B | $359M | -- | |
| Ending Cash (CF) | $44.9B | $54.9B | $51B | $39B | -- | |
| Levered Free Cash Flow | $15.7B | $13.5B | $10.4B | $6.3B | -- | |
Get CVS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CVS
Sector
P/E ratio
17.88x
23.02x
PEG ratio
0.07x
0.00x
P/B ratio
1.09x
1.55x
Price / LTM sales
0.22x
1.59x
Growth Metrics
CVS
Sector
Revenue growth
4.15%
6.4%
Earnings growth
-17.72%
8.33%
Revenue (5-year growth)
7.74%
8.25%
Earnings forecast
$1.62
-$0.19
Profitability
CVS
Sector
Profitability FY 2024
$51.4B
$54.8M
Return on invested capital
3.29%
-14.83%
Return on assets
1.84%
-11.9%
Return on equity
6.12%
-17.27%
Earnings Date
Last Earnings Date
Feb
12
Next Earnings Date
May
1
Estimated Next Earnings Date
May
14
Balance Sheet
CVS
Sector
Total cash
$11B
$40.5M
Short term investments
$2.4B
$36.1M
Total assets
$253.2B
$122.5M
Long term debt
$66.3B
$9.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 34x
Alerts
Buy
72
EFX alert for Apr 23
Equifax [EFX] is up 13.86% over the past day.
Buy
51
CALX alert for Apr 23
Calix [CALX] is up 13.26% over the past day.
Sell
38
NOC alert for Apr 23
Northrop Grumman [NOC] is down 12.3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
